France removes state funding for dementia drugs

17 January 2020 - The first country in Europe to act on concerns over limited effectiveness ...

Read more →

Could or should we use MCDA in the French HTA process?

3 December 2019 - Over the last decade, an increasing literature has been highlighting the benefits of introducing multi-criteria decision analysis ...

Read more →

French Authorities approve national reimbursement of Orkambi (lumacaftor/ivacaftor) for eligible people ages two and older with cystic fibrosis

20 November 2019 - Vertex Pharmaceuticals today announced that the French Authorities (Comité économique des produits de santé, or CEPS) ...

Read more →

Transparency Commission publishes its opinion for Kymriah

14 December 2018 - Opinion published following an examination of written submissions on 12 December 2018. ...

Read more →

Transparency Commission publishes its opinion for Yescarta

7 December 2018 - Opinion published following an examination of written submissions on 5 December 2018. ...

Read more →

Lojuxta to be reimbursed in France

17 October 2018 - Amryt's lead commercial product now available in all five of the EU's largest markets ...

Read more →

Axumin (fluciclovine (18F)) receives positive recommendation from Transparency Committee of the French HAS for use in PET imaging of suspected recurrent prostate cancer

2 October 2018 - Blue Earth Diagnostics, a leading molecular imaging diagnostics company, today announced that the Transparency Committee of ...

Read more →

Agenda for September 5 TC meeting

3 September 2018 - HAS has posted the agenda for the next scheduled TC meeting. ...

Read more →

Agenda for July 11 TC meeting

5 July 2018 - HAS has posted the agenda for the next scheduled TC meeting. ...

Read more →

Agenda for June 27 TC meeting

22 June 2018 - HAS has posted the agenda for the next scheduled TC meeting. ...

Read more →

Agenda for 16 May TC meeting

11 May 2018 - HAS has posted the agenda for the next scheduled TC meeting. ...

Read more →

A new incentive to encourage the prescription of biosimilars

26 April 2018 - The Directorate General of Health Care Supply and the Directorate General of Social Security published a ...

Read more →

Agenda for April 18 meeting

12 April 2018 - HAS has posted the agenda for the next scheduled TC meeting. ...

Read more →

Agenda for 4 April TC meeting

29 March 2018 - HAS has posted the agenda for the next scheduled TC meeting. ...

Read more →

Using real world data in health technology assessment (HTA) practice: a comparative study of five HTA agencies

21 March 2018 - This study examines whether real world data is incorporated in health technology assessment (HTA) of melanoma drugs ...

Read more →